321 related articles for article (PubMed ID: 26168044)
1. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
[TBL] [Abstract][Full Text] [Related]
2. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors.
Tisch U; Schlesinger I; Ionescu R; Nassar M; Axelrod N; Robertman D; Tessler Y; Azar F; Marmur A; Aharon-Peretz J; Haick H
Nanomedicine (Lond); 2013 Jan; 8(1):43-56. PubMed ID: 23067372
[TBL] [Abstract][Full Text] [Related]
3. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
Williams SM; Schulz P; Sierks MR
Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
[TBL] [Abstract][Full Text] [Related]
4. Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease.
Kaerst L; Kuhlmann A; Wedekind D; Stoeck K; Lange P; Zerr I
J Alzheimers Dis; 2014; 38(1):63-73. PubMed ID: 23948928
[TBL] [Abstract][Full Text] [Related]
5. Breath-based non-invasive diagnosis of Alzheimer's disease: a pilot study.
Tiele A; Wicaksono A; Daulton E; Ifeachor E; Eyre V; Clarke S; Timings L; Pearson S; Covington JA; Li X
J Breath Res; 2020 Feb; 14(2):026003. PubMed ID: 31816609
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Exhaled Breath Samples from Patients with Alzheimer's Disease Using Gas Chromatography-Mass Spectrometry and an Exhaled Breath Sensor System.
Lau HC; Yu JB; Lee HW; Huh JS; Lim JO
Sensors (Basel); 2017 Aug; 17(8):. PubMed ID: 28771180
[TBL] [Abstract][Full Text] [Related]
7. Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia.
Vranová HP; Hényková E; Kaiserová M; Menšíková K; Vaštík M; Mareš J; Hluštík P; Zapletalová J; Strnad M; Stejskal D; Kaňovský P
J Neurol Sci; 2014 Aug; 343(1-2):120-4. PubMed ID: 24928081
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.
Johansson P; Mattsson N; Hansson O; Wallin A; Johansson JO; Andreasson U; Zetterberg H; Blennow K; Svensson J
J Alzheimers Dis; 2011; 24(3):537-46. PubMed ID: 21297262
[TBL] [Abstract][Full Text] [Related]
9. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
[TBL] [Abstract][Full Text] [Related]
10. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
11. Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.
Bermejo-Pareja F; Antequera D; Vargas T; Molina JA; Carro E
BMC Neurol; 2010 Nov; 10():108. PubMed ID: 21047401
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
[TBL] [Abstract][Full Text] [Related]
13. Electronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia.
Schnabel RM; Boumans ML; Smolinska A; Stobberingh EE; Kaufmann R; Roekaerts PM; Bergmans DC
Respir Med; 2015 Nov; 109(11):1454-9. PubMed ID: 26440675
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
Goldknopf IL; Park HR; Sabbagh M
Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
[TBL] [Abstract][Full Text] [Related]
15. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease.
Watt AD; Perez KA; Faux NG; Pike KE; Rowe CC; Bourgeat P; Salvado O; Masters CL; Villemagne VL; Barnham KJ
J Alzheimers Dis; 2011; 24(1):47-59. PubMed ID: 21157020
[TBL] [Abstract][Full Text] [Related]
16. Beta-Amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome.
Crino PB; Martin JA; Hill WD; Greenberg B; Lee VM; Trojanowski JQ
Ann Otol Rhinol Laryngol; 1995 Aug; 104(8):655-61. PubMed ID: 7639477
[TBL] [Abstract][Full Text] [Related]
17. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S
J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010
[TBL] [Abstract][Full Text] [Related]
19. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
